The role of probiotics in gastrointestinal surgery

被引:59
作者
Correia, Maria Isabel T. D. [1 ]
Liboredo, Juliana C. [2 ]
Consoli, Marcella L. D. [3 ]
机构
[1] Univ Fed Minas Gerais, Sch Med, Dept Surg, Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Fac Pharm, Food Sci Posgrad Program, Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Sch Med, Surg & Ophthalmol Posgrad Program, Belo Horizonte, MG, Brazil
关键词
Microbiota; Probiotics; Intestinal barrier; Gastrointestinal surgery; POSTOPERATIVE INFECTIOUS COMPLICATIONS; INTESTINAL EPITHELIAL-CELLS; RANDOMIZED CLINICAL-TRIAL; SEVERE ACUTE-PANCREATITIS; BACTERIAL TRANSLOCATION; DOUBLE-BLIND; LACTOBACILLUS-CASEI; ENTERAL NUTRITION; CANCER-SURGERY; FIBER;
D O I
10.1016/j.nut.2011.10.013
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The intestinal microbiota, which is a complex and dynamic population of different bacterial species, represents an important contribution to the health of the host. This microbiota plays a key role by promoting the integrity of the epithelial barrier and the development of mucosal immunity. However, under some stressful situations, such as after gastrointestinal surgery, infectious complications may originate from the intestinal microbiota of the patient. This phenomenon is known as the gut origin of sepsis hypothesis. However, the supply of probiotics has beneficial effects under similar conditions despite some controversial results. Therefore, it is important to carefully assess the efficacy of probiotics in the prevention and treatment of complications in surgical patients and to evaluate the safety of its use. This review provides an overview of the proposed mechanisms of probiotic action and the significant progress in this field, mainly concerning gastrointestinal surgery. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:230 / 234
页数:5
相关论文
共 47 条
[41]   Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery - A randomized controlled trial [J].
Sugawara, Gen ;
Nagino, Masato ;
Nishio, Hideki ;
Ebata, Tomoki ;
Takagi, Kenji ;
Asahara, Takashi ;
Nomoto, Koji ;
Nimura, Yuji .
ANNALS OF SURGERY, 2006, 244 (05) :706-714
[42]   Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota [J].
Takeda, K. ;
Suzuki, T. ;
Shimada, S. -I. ;
Shida, K. ;
Nanno, M. ;
Okumura, K. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 146 (01) :109-115
[43]   Probiotic properties of lactic-acid bacteria: Plenty of scope for fundamental R&D [J].
Tannock, GW .
TRENDS IN BIOTECHNOLOGY, 1997, 15 (07) :270-274
[44]   Emerging Therapies for Intestinal Failure [J].
Tappenden, Kelly A. .
ARCHIVES OF SURGERY, 2010, 145 (06) :528-532
[45]   Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells [J].
Tien, MT ;
Girardin, SE ;
Regnault, B ;
Le Bourhis, L ;
Dillies, MA ;
Coppée, JY ;
Bourdet-Sicard, R ;
Sansonetti, PJ ;
Pédron, T .
JOURNAL OF IMMUNOLOGY, 2006, 176 (02) :1228-1237
[46]   NF-κB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917:: A novel effect of a probiotic bacterium [J].
Wehkamp, J ;
Harder, J ;
Wehkamp, K ;
Wehkamp-von Meissner, B ;
Schlee, M ;
Enders, C ;
Sonnenborn, U ;
Nuding, S ;
Bengmark, S ;
Fellermann, K ;
Schröder, JM ;
Stange, EF .
INFECTION AND IMMUNITY, 2004, 72 (10) :5750-5758
[47]   Probiotics: progress toward novel therapies for intestinal diseases [J].
Yan, Fang ;
Polk, David Brent .
CURRENT OPINION IN GASTROENTEROLOGY, 2010, 26 (02) :95-101